JPRN-UMIN000009137已完成未知
Clinical study of Solifenacin and Imidafenacin in OAB patients with nocturia - Blue-Note study
Clinical Research Support Center Kyushu0 个研究点目标入组 80 人开始时间: 2012年10月18日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients who have administered prohibited substances or done prohibited therapy within the 4weeks before enrollment 2) Patients who started restricted substances and changed usage or dosage of restricted substances for determined period before enrollment 3) Patients with prostate cancer, neurogenic bladder, urethral stricture, chronic bacterial prostatitis, urinary tract infection, urinary tract stones and interstitial cystitis 4) Patients with urinary retention 5) Patients with obstruction of pylorus, duodenum and gut and patients with paralytic ileus 6) Patients with decrease of enterokinesis and gastrointestinal tract tension 7) Patients with closure-angle glaucoma 8) Patients with myasthenia gravis 9) Patients with serious liver dysfunction, kidney dysfunction and heart disease. 10) Hypersensitivity to anti-cholinergic agents. 11) Residual urine volume is more than 100mL 12) Patients with polyuria 13) Any other patients who are regarded as unsuitable for this study by the investigator
研究者
相似试验
招募中
2 期
Comparison of the efficacy of solifenacin and duloxetine in the treatment of overactive bladder diseaseIRCT20191010045047N1Kerman University of Medical Sciences60
已完成
4 期
Comparative evaluation of solifenacin and darifenacin for prevention of catheter related bladder discomfortCTRI/2014/08/004934Apollo Hospitals Bilaspur90
招募中
1 期
BeDryDaytime urinary incontinence and overactive bladderMedDRA version: 21.1Level: LLTClassification code: 10021642Term: Incontinence of urine Class: 10038359MedDRA version: 20.0Level: LLTClassification code: 10008523Term: Childhood incontinence Class: 10038359CTIS2023-510187-13-00Region Midtjylland236
已完成
1 期
Investigate the Effect of Food on the Pharmacokinetic of JLP-1207 in Healthy Male VolunteersLUTSOveractive BladderBenign Prostatic HyperplasiaNCT02447367Jeil Pharmaceutical Co., Ltd.54
已完成
2 期
A Study to Evaluate the Efficacy, Safety and Tolerability of Mirabegron and Solifenacin Succinate Alone and in Combination for the Treatment of Overactive BladderUrologic DiseasesUrinary Bladder DiseasesUrological ManifestationsSigns and SymptomsUrinary Bladder, OveractiveNCT01340027Astellas Pharma Europe B.V.1,307